Penicillin derivatives inhibit the SARS-CoV-2 main protease by reaction with its nucleophilic cysteine

<p>The SARS-CoV-2 main protease (M<sup>pro</sup>) is a medicinal chemistry target for COVID-19 treatment. Given the clinical efficacy of &beta;-lactams as inhibitors of bacterial nucleophilic enzymes, they are of interest as inhibitors of viral nucleophilic serine and cysteine...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Malla, TR, Brewitz, L, Muntean, D-G, Aslam, H, Owen, CD, Salah, E, Tumber, A, Lukacik, P, Strain-Damerell, C, Mikolajek, H, Walsh, MA, Schofield, CJ
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: American Chemical Society 2022